Sensus Healthcare Inc. (NASDAQ:SRTS) does about 289.54K shares in volume on a normal day but saw 183835 shares change hands in Friday trading. The company now has a market cap of 152.84M USD. Its current market price is $7.32, marking an increase of 2.66% compared to the previous close of $7.13. The 52 week high reached by this stock is $15.25 whilst the lowest price level in 52 weeks is $5.58. The script in recent trading has seen the stock touch a high of $7.38 and a low of $7.08.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sensus Healthcare Inc. (SRTS) has a 20-day trading average at $8.43 and the current price is -52.00% off the 52-week high compared with 31.18% distance from its 52-week low. The 50-day simple moving average of the closing price is $7.83 and its 200-day simple moving average is $9.72. If we look at the stock’s price movements over the week, volatility stands at 5.61%, which increases to 5.78% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 38.79 to suggest the stock is neutral.
The consensus objective for the share price is $15.00, suggesting that the stock has a potential upside of 51.2% over the period.
Alliance Global Partners upgraded its price target at $2.40-$4.25.
The current price level is -14.06%, -6.32%, and -24.67% away from its SMA20, SMA50, and SMA200 respectively, with the SRTS price moving above the 50-day SMA on February 17. Sensus Healthcare Inc. (SRTS) stock is up 3.98% over the week and -16.34% over the past month. Its price is -1.35% year-to-date and -30.02% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2022, with the company’s earnings per share (EPS) of $0.17 below consensus estimates by -$0.06. SRTS’s earnings per share are forecast to shrink by -39.00% this year and -5.60% over next year. Expected sales for next quarter are $13.58 million, which analysts say will come at $51.34 million for the current fiscal year and next year at $55 million. In addition, estimates put the company’s current quarterly revenue at an average of $11.09 million.
To reach the target analysts have set, the stock logically needs to grow 51.2 percent from here.
Outstanding shares total 16.48M with insiders holding 23.29% of the shares and institutional holders owning 36.49% of the company’s common stock. The company has a return on investment of 15.80% and return on equity of 62.50%. The price to earnings ratio (P/E ratio) amounts to 4.55 while the forward price to earnings ratio is 8.93. The beta has a value of 0.62. Price to book ratio is 2.56 and price to sales ratio is 3.43.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has added its position in Sensus Healthcare Inc. (SRTS) to 552,662 shares, mirroring a recent increase by 6.55%. Vanguard Total Stock Market Index added 33982.0 shares of Sensus Healthcare Inc. common stock bringing its total worth to about $5.05 million at the end of recent close, SEC documents show.
